Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
The global market for Codeine was estimated to be worth US$ 272.9 million in 2023 and is forecast to a readjusted size of US$ 182.8 million by 2030 with a CAGR of -5.5% during the forecast period 2024-2030
Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Codeine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Codeine by region & country, by Ingredient, and by Application.
The Codeine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine.
Market Segmentation
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Ingredient:
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Codeine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Ingredient, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Codeine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Codeine in country level. It provides sigmate data by Ingredient, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Codeine Product Introduction
1.2 Global Codeine Market Size Forecast
1.2.1 Global Codeine Sales Value (2019-2030)
1.2.2 Global Codeine Sales Volume (2019-2030)
1.2.3 Global Codeine Sales Price (2019-2030)
1.3 Codeine Market Trends & Drivers
1.3.1 Codeine Industry Trends
1.3.2 Codeine Market Drivers & Opportunity
1.3.3 Codeine Market Challenges
1.3.4 Codeine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Codeine Players Revenue Ranking (2023)
2.2 Global Codeine Revenue by Company (2019-2024)
2.3 Global Codeine Players Sales Volume Ranking (2023)
2.4 Global Codeine Sales Volume by Company Players (2019-2024)
2.5 Global Codeine Average Price by Company (2019-2024)
2.6 Key Manufacturers Codeine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Codeine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Codeine
2.9 Codeine Market Competitive Analysis
2.9.1 Codeine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Codeine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Codeine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Ingredient
3.1 Introduction by Ingredient
3.1.1 Single-ingredient Codeine
3.1.2 Multi-ingredient Medications
3.2 Global Codeine Sales Value by Ingredient
3.2.1 Global Codeine Sales Value by Ingredient (2019 VS 2023 VS 2030)
3.2.2 Global Codeine Sales Value, by Ingredient (2019-2030)
3.2.3 Global Codeine Sales Value, by Ingredient (%) (2019-2030)
3.3 Global Codeine Sales Volume by Ingredient
3.3.1 Global Codeine Sales Volume by Ingredient (2019 VS 2023 VS 2030)
3.3.2 Global Codeine Sales Volume, by Ingredient (2019-2030)
3.3.3 Global Codeine Sales Volume, by Ingredient (%) (2019-2030)
3.4 Global Codeine Average Price by Ingredient (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Narcotic Analgesic
4.1.2 Antitussive
4.1.3 Others
4.2 Global Codeine Sales Value by Application
4.2.1 Global Codeine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Codeine Sales Value, by Application (2019-2030)
4.2.3 Global Codeine Sales Value, by Application (%) (2019-2030)
4.3 Global Codeine Sales Volume by Application
4.3.1 Global Codeine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Codeine Sales Volume, by Application (2019-2030)
4.3.3 Global Codeine Sales Volume, by Application (%) (2019-2030)
4.4 Global Codeine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Codeine Sales Value by Region
5.1.1 Global Codeine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Codeine Sales Value by Region (2019-2024)
5.1.3 Global Codeine Sales Value by Region (2025-2030)
5.1.4 Global Codeine Sales Value by Region (%), (2019-2030)
5.2 Global Codeine Sales Volume by Region
5.2.1 Global Codeine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Codeine Sales Volume by Region (2019-2024)
5.2.3 Global Codeine Sales Volume by Region (2025-2030)
5.2.4 Global Codeine Sales Volume by Region (%), (2019-2030)
5.3 Global Codeine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Codeine Sales Value, 2019-2030
5.4.2 North America Codeine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Codeine Sales Value, 2019-2030
5.5.2 Europe Codeine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Codeine Sales Value, 2019-2030
5.6.2 Asia Pacific Codeine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Codeine Sales Value, 2019-2030
5.7.2 South America Codeine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Codeine Sales Value, 2019-2030
5.8.2 Middle East & Africa Codeine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Codeine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Codeine Sales Value
6.2.1 Key Countries/Regions Codeine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Codeine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Codeine Sales Value, 2019-2030
6.3.2 United States Codeine Sales Value by Ingredient (%), 2023 VS 2030
6.3.3 United States Codeine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Codeine Sales Value, 2019-2030
6.4.2 Europe Codeine Sales Value by Ingredient (%), 2023 VS 2030
6.4.3 Europe Codeine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Codeine Sales Value, 2019-2030
6.5.2 China Codeine Sales Value by Ingredient (%), 2023 VS 2030
6.5.3 China Codeine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Codeine Sales Value, 2019-2030
6.6.2 Japan Codeine Sales Value by Ingredient (%), 2023 VS 2030
6.6.3 Japan Codeine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Codeine Sales Value, 2019-2030
6.7.2 South Korea Codeine Sales Value by Ingredient (%), 2023 VS 2030
6.7.3 South Korea Codeine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Codeine Sales Value, 2019-2030
6.8.2 Southeast Asia Codeine Sales Value by Ingredient (%), 2023 VS 2030
6.8.3 Southeast Asia Codeine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Codeine Sales Value, 2019-2030
6.9.2 India Codeine Sales Value by Ingredient (%), 2023 VS 2030
6.9.3 India Codeine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Taiji
7.1.1 Taiji Company Information
7.1.2 Taiji Introduction and Business Overview
7.1.3 Taiji Codeine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Taiji Codeine Product Offerings
7.1.5 Taiji Recent Development
7.2 Mallinckrodt
7.2.1 Mallinckrodt Company Information
7.2.2 Mallinckrodt Introduction and Business Overview
7.2.3 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Mallinckrodt Codeine Product Offerings
7.2.5 Mallinckrodt Recent Development
7.3 TEVA
7.3.1 TEVA Company Information
7.3.2 TEVA Introduction and Business Overview
7.3.3 TEVA Codeine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 TEVA Codeine Product Offerings
7.3.5 TEVA Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Information
7.4.2 Johnson & Johnson Introduction and Business Overview
7.4.3 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Johnson & Johnson Codeine Product Offerings
7.4.5 Johnson & Johnson Recent Development
7.5 Medreich
7.5.1 Medreich Company Information
7.5.2 Medreich Introduction and Business Overview
7.5.3 Medreich Codeine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Medreich Codeine Product Offerings
7.5.5 Medreich Recent Development
7.6 Sanofi Aventis
7.6.1 Sanofi Aventis Company Information
7.6.2 Sanofi Aventis Introduction and Business Overview
7.6.3 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Sanofi Aventis Codeine Product Offerings
7.6.5 Sanofi Aventis Recent Development
7.7 Cipla
7.7.1 Cipla Company Information
7.7.2 Cipla Introduction and Business Overview
7.7.3 Cipla Codeine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Cipla Codeine Product Offerings
7.7.5 Cipla Recent Development
7.8 Hikma
7.8.1 Hikma Company Information
7.8.2 Hikma Introduction and Business Overview
7.8.3 Hikma Codeine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Hikma Codeine Product Offerings
7.8.5 Hikma Recent Development
7.9 Pharmaceutical Associates
7.9.1 Pharmaceutical Associates Company Information
7.9.2 Pharmaceutical Associates Introduction and Business Overview
7.9.3 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Pharmaceutical Associates Codeine Product Offerings
7.9.5 Pharmaceutical Associates Recent Development
7.10 Novartis
7.10.1 Novartis Company Information
7.10.2 Novartis Introduction and Business Overview
7.10.3 Novartis Codeine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Novartis Codeine Product Offerings
7.10.5 Novartis Recent Development
7.11 Apotex
7.11.1 Apotex Company Information
7.11.2 Apotex Introduction and Business Overview
7.11.3 Apotex Codeine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Apotex Codeine Product Offerings
7.11.5 Apotex Recent Development
7.12 Mylan
7.12.1 Mylan Company Information
7.12.2 Mylan Introduction and Business Overview
7.12.3 Mylan Codeine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Mylan Codeine Product Offerings
7.12.5 Mylan Recent Development
7.13 Aristo Pharma GmbH
7.13.1 Aristo Pharma GmbH Company Information
7.13.2 Aristo Pharma GmbH Introduction and Business Overview
7.13.3 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Aristo Pharma GmbH Codeine Product Offerings
7.13.5 Aristo Pharma GmbH Recent Development
7.14 Lannett Company
7.14.1 Lannett Company Company Information
7.14.2 Lannett Company Introduction and Business Overview
7.14.3 Lannett Company Codeine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Lannett Company Codeine Product Offerings
7.14.5 Lannett Company Recent Development
7.15 Laboratoire Riva
7.15.1 Laboratoire Riva Company Information
7.15.2 Laboratoire Riva Introduction and Business Overview
7.15.3 Laboratoire Riva Codeine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Laboratoire Riva Codeine Product Offerings
7.15.5 Laboratoire Riva Recent Development
8 Industry Chain Analysis
8.1 Codeine Industrial Chain
8.2 Codeine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Codeine Sales Model
8.5.2 Sales Channel
8.5.3 Codeine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
*If Applicable.